HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prospective study of low-dose ristocetin-induced platelet aggregation to identify type 2B von Willebrand disease (VWD) and platelet-type VWD in children.

Abstract
Type 2B von Willebrand disease (VWD2B) and platelet-type von Willebrand disease (PT-VWD) are rare bleeding disorders characterised by an increased ristocetin-induced platelet aggregation (RIPA) at low dose of ristocetin. It was the objective of this study to detect children with VWD2B and PT-VWD using RIPA at low dose of ristocetin (0.5 mg/ml) in the screening evaluation of bleeding disorders, and to analyse the phenotypic data along with the molecular findings. Over a 14-year period, 641 children with personal and family bleeding symptoms or bleeding from birth with previously uncharacterised haemostatic disorders were prospectively studied. Six unrelated patients (0.93%) showed RIPA at low dose of ristocetin. RIPA-based mixing studies identified that the plasma of the six probands and at least one parent from five unrelated families induced aggregation of normal platelets with the addition of low-dose ristocetin. None of the probands' platelets showed aggregation with cryoprecipitate. Low ristocetin cofactor activity/VWF antigen ratio with absent collagen binding activity or thrombocytopenia were detected respectively in only two patients. Molecular analysis of exon 28 of the VWF gene identified mutations in only three patients. No mutation in the GP1BA gene was found. In this large prospective paediatric study, the screening approach including RIPA at low dose of ristocetin permitted the detection of patients with VWD2B that would otherwise have been missed. No patient with phenotype or genotype of PT-VWD was identified. Heterogeneity of bleeding symptoms and phenotypic parameters were found among members of the same family.
AuthorsJuan Pablo Frontroth, Mirta Hepner, Gabriela Sciuccati, Aurora Feliú Torres, Graciela Pieroni, Mariana Bonduel
JournalThrombosis and haemostasis (Thromb Haemost) Vol. 104 Issue 6 Pg. 1158-65 (Dec 2010) ISSN: 2567-689X [Electronic] Germany
PMID20941465 (Publication Type: Journal Article)
Chemical References
  • von Willebrand Factor
  • Ristocetin
Topics
  • Adolescent
  • Argentina
  • Blood Coagulation Tests
  • Child
  • Child, Preschool
  • DNA Mutational Analysis
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Genotype
  • Humans
  • Infant
  • Male
  • Mutation
  • Phenotype
  • Platelet Aggregation (genetics)
  • Platelet Function Tests
  • Predictive Value of Tests
  • Prognosis
  • Prospective Studies
  • Ristocetin (administration & dosage)
  • von Willebrand Disease, Type 2 (blood, diagnosis, genetics)
  • von Willebrand Diseases (blood, diagnosis, genetics)
  • von Willebrand Factor (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: